Qaytona is free while it's in beta — Get started

Ingredients

Phosphorus

Phosphate supplementation · Phosphorus supplementation

Snapshot

IndicationsContraindications
  • Refeeding hypophosphatemia1
  • Preterm metabolic bone disease2, 3
  • Hypophosphatemic rickets1
  • Documented hypophosphatemia4
  • Advanced kidney disease1
  • Hyperphosphatemia1
  • Infants, supplements without supervision1

Phosphorus is an essential mineral present in foods and dietary supplements, forming part of bone, teeth, cell membranes, and the energy carrier adenosine triphosphate (ATP)1. Supplementation exists to correct or prevent low phosphate, which rarely arises from diet alone and usually reflects a medical condition.1, 5 Uses follow from that: refeeding hypophosphatemia in severe malnutrition, bone mineralization in preterm infants, and inherited phosphate-wasting rickets1, 5. Most adults already meet needs through food.

Human evidence is mostly observational or retrospective, and it points one direction in neonates.2, 3, 6 Early parenteral calcium and phosphorus lowered metabolic bone disease rates in very low birth weight infants in retrospective and quality-improvement cohorts2, 3, 6. In intensive care unit (ICU) patients with acute pancreatitis, a 2025 retrospective database analysis linked a higher phosphorus-to-calcium ratio at admission with in-hospital mortality; no trial has tested whether correcting it changes outcomes. Supplements typically supply phosphate salts or phospholipids, usually in combination with calcium or in multivitamin and mineral products; see Form comparison1.

The main caution is kidney handling: when function declines, phosphate cannot be excreted efficiently and serum levels rise, and higher serum phosphorus tracks with mortality in chronic kidney disease1, 7. Per the National Institutes of Health Office of Dietary Supplements fact sheet, its upper limits do not apply to people receiving supplemental phosphorus under medical supervision1.

Last updated October 17, 2026. Read how we make monographs.

In the full monograph

50 sources, 43 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1NIH ODSods.od.nih.govNIH Office of Dietary Supplements — Fact Sheet for Health Professionals
  2. 2Effect of early preventive supplementation with calcium and phosphorus on metabolic bone disease in premature infants.pubmed.ncbi.nlm.nih.govXu, Ma, Cheng et al. · BMC pediatrics · 2024 · Pubmed
  3. 3Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: a quality improvement initiative.pubmed.ncbi.nlm.nih.govKrithika, Balakrishnan, Amboiram et al. · BMJ open quality · 2022 · Pubmed
  4. 4Long-Term Follow-up of Hypophosphatemic Bone Disease Associated With Elemental Formula Use: Sustained Correction of Bone Disease After Formula Change or Phosphate Supplementation.pubmed.ncbi.nlm.nih.govEswarakumar, Ma, Ward et al. · Clinical pediatrics · 2020 · Pubmed
  5. 5Early phosphate supplementation reduces refeeding syndrome and improves clinical outcomes in very-preterm infants: A retrospective cohort study.pubmed.ncbi.nlm.nih.govAssfour, Alshaikh, AlMahmoud et al. · Clinical nutrition ESPEN · 2026 · Pubmed
  6. 6Appropriate Phosphorus Intake by Parenteral Nutrition Prevents Metabolic Bone Disease of Prematurity in Extremely Low-Birth-Weight Infants.pubmed.ncbi.nlm.nih.govMotokura, Tomotaki, Hanaoka et al. · JPEN. Journal of parenteral and enteral nutrition · 2021 · Pubmed
  7. 7Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.pubmed.ncbi.nlm.nih.govPalmer, Hayen, Macaskill et al. · JAMA · 2011 · Pubmed